Current Pharmaceutical Design

Pharmacological Regulators of Intracellular Calcium Release Channels
pp. 2428-2442(15)
Authors: Duncan J. West,; Alan J. Williams,

Modulation of Ion Channels in Pulmonary Arterial Hypertension
pp. 2443-2455(13)
Authors: Christelle Guibert,; Roger Marthan,; Jean-Pierre Savineau,

Involvement of Membrane Channels in Autoimmune Disorders
pp. 2456-2468(13)
Authors: Zoltan Varga,; Peter Hajdu,; Gyorgy Panyi,; Rezso Gaspar,; Zoltan Krasznai,

Editorial [Hot Topic: Interference of Signalling Cascades of Axon Growth Inhibitory Molecules as Therapeutic Targets of CNS Lesions (Executive Editor: D. Bagnard)]
pp. 2469-2469(1)
Author: Dominique Bagnard,

Targeting the Nogo-A Signalling Pathway to Promote Recovery Following Acute CNS Injury
pp. 2470-2484(15)
Authors: A. R. Walmsley,; A. K. Mir,

Overcoming Chondroitin Sulphate Proteoglycan Inhibition of Axon Growth in the Injured Brain: Lessons from Chondroitinase ABC
pp. 2485-2492(8)
Authors: J.A. Del Rio,; E. Soriano,

Rho-ROCK Inhibitors as Emerging Strategies to Promote Nerve Regeneration
pp. 2493-2499(7)
Authors: Takekazu Kubo,; Katsuhiko Hata,; Atsushi Yamaguchi,; Toshihide Yamashita,

DNA Vaccine and the CNS Axonal Regeneration
pp. 2500-2506(7)
Authors: Du-yu Nie,; Gang Xu,; Sohail Ahmed,; Zhi-cheng Xiao,

Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury
pp. 2507-2518(12)
Authors: J. Du,; C. Fu,; D.W. Sretavan,

Using Nanotechnology to Design Potential Therapies for CNS Regeneration
pp. 2519-2528(10)
Authors: R.G. Ellis-Behnke,; L.A. Teather,; G.E. Schneider,; K.-F. So,

Physiological Roles of Neurite Outgrowth Inhibitors in Myelinated Axons of the Central Nervous System-Implications for the Therapeutic Neutralization of Neurite Outgrowth Inhibitors
pp. 2529-2537(9)
Authors: Quan-Hong Ma,; Wu-Lin Yang,; Du-Yu Nie,; Gavin S. Dawe,; Zhi-Cheng Xiao,